Vaccinated vs Unvaccinated Study Finally Being Done

Vaccinated vs Unvaccinated Study Finally Being Done

When wondering minds begin to question whether or not there really is hard evidence that either proves or disproves the dangers of vaccinations, one may often feel like they are hitting a brick wall.  You can search high and low and you will find varying opinions and studies on both sides of the spectrum.  But how is it possible to make a fully educated decision on your own if the facts aren’t readily available?  Truth is- it’s very difficult.  But, there is hope on the horizon, according to one doctor, as a new study attempts to examine links between vaccinations and children’s long term health.

According to an article found at Health Impact News Daily, the author, Suzanne Humphries, MD says one way to find out would be to compare vaccinated children with unvaccinated children, and a new study is presenting hope to those desperately seeking these answers.

The study is called, “Vaccination Status and Health Outcomes among Homeschool Children.” The pilot study involved four states. That data has not been fully analyzed. The upcoming study will be nationwide in the USA.

To continue reading Vaccinated vs Unvaccinated Study Finally Being Done

NIH Vaccine Chief Joins Big Pharma

Gary Nabel, one of National Institutes of Health’s most prominent researchers who heads up the agency’s Vaccine Research Center (VRC) – has announced that he will become chief scientific officer at Sanofi this month.

Dr. Nabel joins Sanofi from the National Institutes of Health, where he served as Director of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases since 1999. During his tenure at the NIH, Dr. Nabel provided overall direction and scientific leadership of the basic, clinical, and translational research activities of the VRC and guides development of novel vaccine strategies against HIV and other emerging and re-emerging infectious diseases, including Ebola/Marburg hemorrhagic fevers, influenza, chikungunya and other viruses.

Nabel, when talking about his former VRC position said that there was “nothing about the job that I don’t like.”  He said he decided to switch to Sanofi because it would cut his commute time.

It’s a position he is ideally suited for, considering his extensive connections with the government agency, according to Dr. Mercola.

Elias Zerhouni, the former director of the NIH, actually recruited him for the position. Zerhouni is now the head of Sanofi-Aventis’ research labs, as well as a professor at Johns Hopkins School of Medicine, a member of the Board of Trustees at the Mayo Clinic, and a senior fellow for the Bill & Melinda Gates Foundation’s Global Health Program.

This comes as no surprise, considering Zerhouni is no stranger to conflicts of interest, said Dr. Mercola.

To continue reading NIH Vaccine Chief Trades Sides & Joins Big Pharma

Flu Vaccine Usefulness Seriously Questioned

Researchers reported that influenza vaccinations provide only modest protection for healthy young and middle-age adults, and little, if any protection, for those 65 and older, who are most likely to succumb to the illness or its complications.

Tis’ the time for the flu and some are questioning the value of getting the flu vaccine.

Scientists at the Center for Infectious Disease Research and Policy at the University of Minnesota released a report seriously questioning the efficacy of the flu vaccine.

Researchers reported that influenza vaccinations provide only modest protection for healthy young and middle-age adults, and little, if any protection, for those 65 and older, who are most likely to succumb to the illness or its complications. Moreover, the report’s authors concluded, federal vaccination recommendations, which have expanded in recent years, are based on inadequate evidence and poorly executed studies.

To continue reading Researchers Reassess Flu Shot as the Season Draws Near

Sanofi Typhoid Vaccine Batches Recalled

The Medicines and Healthcare products Regulatory Agency (MHRA) recently issued a drug alert to healthcare professionals advising them that the manufacturer Sanofi Pasteur MSD has recalled 16 batches of their typhoid vaccine, Typhim Vi.

This recall is due to concerns about the effectiveness of the vaccine in some syringes distributed from January 7, 2011 following filling problems in the manufacturing process. Therefore some patients who have been vaccinated with Typhim Vi may not be fully protected against the disease.

Typhim Vi vaccine is used to immunize people against S. typhi, the organism that causes typhoid fever, in those aged two or older.

MHRA Head of Defective Medicines Report Centre, Ian Holloway said:

“There are no concerns over the safety of this vaccine but the recall has taken place because the vaccine may not be as effective as it should be.

“Anyone who has been to a typhoid region of the world and has a fever, abdominal pain and vomiting should contact a healthcare professional. They can also give them information and advice about minimising the risk of getting typhoid.”

To continue reading Sanofi Typhoid Vaccine Batches Recalled

More Parents Declining Immunizations: One State Acts

Washington State was backed up into a corner.  Their state was running last in vaccinated individuals and they knew they had to do something about it.

Their state allowed parents to simply sign a form at the school, allowing their children to skip immunizations, and because it was so easy, the share of kindergartners whose parents opted out of state immunization requirements more than doubled in the decade that ended in 2008, peaking at 7.6 percent in the 2008-9 school year, according to the state’s Health Department, raising alarm among public health experts, according to The New York Times.

Therefore, last year, the Legislature adopted a law that makes it harder for parents to avoid getting their children vaccinated, by requiring them to get a doctor’s signature if they wish to do so.

And, apparently, it was a successful plan, as since then, the opt-out rate has fallen fast, by a quarter, setting an example for other states with easy policies.

To continue reading Washington State Makes It Harder to Opt Out of Immunizations

Risk Of Viral Reactivation With Shingles Vaccine

Risk Of Vaccine Reactivating Latent Varicella Zoster From The Vaccine

The Zostavax vaccine is essentially the same vaccine as that used for chickenpox, except significantly stronger.

Zostavax contains live varicella zoster virus. The virulence of the virus is reduced or “attenuated”. Attenuated vaccines are designed to activate the immune system with the decreased risk of actually developing the disease. Zostavax is developed from a live attenuated version of the Oka/Merck VZV vaccine strain.

A risk of using a live virus vaccine is that it is not weakened enough or “under -attenuated”. Under-attenuated live virus creates an increased risk of developing the disease the vaccine was to prevent. Once injected, attenuated live virus has been shown to recombine into more virulent strains causing disease.

Read More: Risk Of Viral Reactivation With Shingles Vaccine

Those Vaccinated For Flu More Likely To Get Sick

During the 2009 flu pandemic in Canada, public health officials noticed that vaccinated individuals were MORE likely to get the flu those that were unvaccinated. Initially this phenomenon was not taken seriously, however a new study reveals differently.

Canadian researchers noticed in the early weeks of the pandemic that people who got a flu shot for the 2008-2009 winter seemed to be more likely to get infected with the pandemic virus than people who hadn’t received a flu shot.

A Canadian Problem?

Five studies done in several provinces showed the same puzzling and unsettling results. But initially research outside of Canada did not, and the effect was dismissed as “the Canadian problem.”

News of the unexpected findings broke at a time when countries in North America and parts of Europe were getting ready to start vaccinating their populations against the pandemic virus.

Some jurisdictions were also trying to figure out whether to offer the seasonal flu vaccine they had purchased — similar to the 2008-2009 shot — along with the pandemic vaccine, in case the seasonal flu viruses continued to circulate. Quebec opted not to offer the seasonal vaccine because of the concerns raised by the studies. (more…)

Follow

Get every new post delivered to your Inbox.